Scarica l'app Stockscreener
0.65
28.57%
-0.26
Dopo l'orario di chiusura:
.65
Precedente Chiudi:
$0.91
Aprire:
$0.8
Volume 24 ore:
2.16M
Relative Volume:
3.58
Capitalizzazione di mercato:
$1.56M
Reddito:
-
Utile/perdita netta:
$-8.44M
Rapporto P/E:
-4.1747
EPS:
-0.1557
Flusso di cassa netto:
$-4.41M
1 W Prestazione:
-50.38%
1M Prestazione:
-16.67%
6M Prestazione:
-98.28%
1 anno Prestazione:
-98.23%
Intervallo 1D:
$0.6454
$0.80
Intervallo di 1 settimana:
$0.6454
$1.49
Portata 52W:
$0.5949
$52.40
Clearmind Medicine Inc Stock (CMND) Company Profile
Nome
Clearmind Medicine Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare CMND vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.65 | 2.18M | 0 | -8.44M | -4.41M | -0.1557 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Clearmind Medicine Inc Borsa (CMND) Ultime notizie
Clearmind shares surge as CMND-100 achieves primary endpoint in clinical trial - MSN
Clearmind gets safety board nod to continue alcohol disorder trial - Investing.com
Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial - The Manila Times
Alcohol disorder drug advances after no serious adverse events - Stock Titan
Clearmind Medicine (CMND) raises $1.58M cash via $1.75M notes - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday SessionAdagio Medical Holdings (NASDAQ:ADGM), Allog - Benzinga
Crude Oil Falls Sharply; Wells Fargo Earnings Miss ViewsAvanos Medical (NYSE:AVNS), Clearmind Medicine - Benzinga
Clearmind (Nasdaq: CMND) CMND-100 meets key safety goal in AUD trial - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Clearmind’s CMND-100 meets primary endpoint in phase I/IIa trial - Investing.com India
Clearmind Medicine's CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder - Bitget
Clearmind Medicine Inc. Reports Positive Phase I/IIa Trial Results for CMND-100 in Treating Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine stock surges on phase trial results By Investing.com - Investing.com Australia
Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder - The Manila Times
Clearmind Medicine stock surges on phase trial results - Investing.com
Alcohol use disorder drug clears early safety test at higher dose - Stock Titan
CMND Stock Price, Quote & Chart | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
CMND Forecast, Price Target & Analyst Ratings | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
CMND PE Ratio & Valuation, Is CMND Overvalued - Intellectia AI
CMND Technical Analysis & Stock Price Forecast - Intellectia AI
Clearmind gets safety board approval to continue AUD trial - Investing.com
Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial - TipRanks
Bull Bear: What analysts say about Clearmind Medicine Inc stockWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Clearmind completes treatment for 18 participants in AUD trial By Investing.com - Investing.com South Africa
[EFFECT] Clearmind Medicine Inc. SEC Filing - Stock Titan
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders - MarketScreener
Clearmind completes treatment for 18 participants in AUD trial - Investing.com
Clearmind Medicine Announces Successful Completion Of Treatment Of Cmnd-100 For Alcohol Use Disorder - TradingView — Track All Markets
Clearmind Medicine (Nasdaq: CMND) completes treatment for 18 CMND-100 patients - Stock Titan
Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder - bitget.com
Clearmind says its alcohol disorder drug trial cleared 18 patients - Stock Titan
Oruka Therapeutics and Clearmind Medicine Vie for Investor Dollars - National Today
Clearmind files patent application in India for psychedelic compounds By Investing.com - Investing.com South Africa
Clearmind files patent application in India for psychedelic compounds - in.investing.com
Clearmind Medicine Files Patent Application In India For Next-Gen Psychedelic Compounds To Treat Mental Health Disorders - TradingView
Clearmind Medicine Inc. Files Patent Application in India for Next-Generation Psychedelic Compounds Targeting Mental Health and Addiction - Quiver Quantitative
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer) | CMND SEC FilingForm 6-K - Stock Titan
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to ... - Caledonian Record
Market Overview: Is Clearmind Medicine Inc in a bullish channel2026 Big Picture & Real-Time Buy Signal Alerts - baoquankhu1.vn
[POS AM] Clearmind Medicine Inc. SEC Filing - Stock Titan
CMND SEC FilingsClearmind Medici 10-K, 10-Q, 8-K Forms - Stock Titan
CMND Technical Analysis | Trend, Signals & Chart Patterns | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Analyst Upgrade: Is Clearmind Medicine Inc a turnaround story2026 Catalysts & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Form 6K Clearmind Medicine Inc For: 19 March - Investing.com
[6-K] Clearmind Medicine Inc. Cur... | CMND SEC FilingForm 6-K - Stock Titan
Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder - manilatimes.net
Clearmind Medicine Inc. Advances CMND-100 Clinical Trial for Alcohol Use Disorder with Successful Cohort Treatment - Quiver Quantitative
Clearmind Medicine regains compliance with NASDAQ minimum bid price rule - MSN
Clearmind Medicine secures six patents in Hong Kong By Investing.com - Investing.com South Africa
Clearmind Medicine Inc Azioni (CMND) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):